1-7 of 7
Chiara Cerrato
Close
Sort by
Journal Articles

Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM)

Francesca Gay, MD, Chiara Cerrato, MD, Delia Rota Scalabrini, MD, Monica Galli, MD, Angelo Belotti, MD, Elena Zamagni, MD, Antonio Ledda, MD, Mariella Grasso, MD, Emanuele Angelucci, MD, Anna Marina Liberati, MD, Patrizia Tosi, MD, Francesco Pisani, MD, Stefano Spada, Ombretta Annibali, MD, Anna Baraldi, MD, Paola Omedé, Piero Galieni, MD, Rita Rizzi, MD, Norbert Pescosta, MD, Sonia Ronconi, MD, Donatella Vincelli, MD, Anna Maria Cafro, MD, Massimo Offidani, MD, Antonio Palumbo, MD, Pellegrino Musto, MD, Michele Cavo, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 121.
https://doi.org/10.1182/blood-2018-99-112093
Published: 2018
Journal Articles

Prognostic Implication of Somatic Mutations By Next Generation Sequencing: An Analysis from the Mmrf Commpass Study in Newly Diagnosed Multiple Myeloma Patients

Mattia D'Agostino, MD, Stefania Oliva, Alessandra Larocca, Stefano Spada, Manuela Gambella, Mary DeRome, Michele Cavo, Massimo Aglietta, Massimo Offidani, MD, Jennifer Yesil, MS, Daniela Oddolo, Chiara Cerrato, Giuseppe Rossi, MD, Antonio Ledda, Letizia Canepa, Mariella Grasso, Robert Foa', Daniel Auclair, Pellegrino Musto, Andrea Evangelista, MSc, Francesca Gay, Antonio Palumbo, MD, Mario Boccadoro
Journal: Blood
Blood (2016) 128 (22): 2079.
https://doi.org/10.1182/blood.V128.22.2079.2079
Published: 2016
Journal Articles

Impact of Complete Response on Survival with Either Autologous Stem Cell Transplantation or Conventional Chemotherapy: Results of a Pooled Analysis of 5 Phase III Trials in Newly Diagnosed Multiple Myeloma Patients

Roberto Mina, Alessandra Larocca, Massimo Offidani, Sara Bringhen, Tommaso Caravita, Valeria Magarotto, MD, Lucia Pantani, MD, Francesco Di Raimondo, Alberto Bosi, Iolanda D. Vincelli, Paola Tacchetti, MD, Gianluca Gaidano, Sonia Grandi, Caterina Musolino, Chiara Cerrato, Ludek Pour, Monica Astolfi, Giuseppe Rossi, MD, Fausto Rossini, Maria T. Petrucci, Roberto Ria, Annalisa Pezzi, PhD, Roman Hajek, Michele Cavo, Andrew Spencer, Mario Boccadoro, MD, Antonio Palumbo
Journal: Blood
Blood (2015) 126 (23): 927.
https://doi.org/10.1182/blood.V126.23.927.927
Published: 2015
Journal Articles

Significant Survival Improvement with Maintenance in Patients Achieving a Complete Response: Pooled Analysis of 4 Italian Phase III Trials in Newly Diagnosed Multiple Myeloma Patients

Chiara Cerrato, Francesca Gay, Maria Teresa Petrucci, Pellegrino Musto, Gianluca Gaidano, Massimo Offidani, Tommasina Guglielmelli, Marco Salvini, Francesca Patriarca, Elena Ponticelli, Gianpietro Semenzato, Francesco Di Raimondo, Roberto Mina, Nicola Cascavilla, Dina Ben Yehuda, Daniela Oddolo, Paolo Corradini, Lucio Catalano, Paolo Di Bartolomeo, Roman Hájek, Andrew Spencer, Mario Boccadoro, MD, Antonio Palumbo
Journal: Blood
Blood (2015) 126 (23): 1974.
https://doi.org/10.1182/blood.V126.23.1974.1974
Published: 2015
Journal Articles

Impact of Autologous Transplantation Vs. Chemotherapy Plus Lenalidomide in Newly Diagnosed Myeloma According to Patient Prognosis: Results of a Pooled Analysis of 2 Phase III Trials

Francesca Gay, MD, Chiara Cerrato, MD, Roman Hajek, Francesco Di Raimondo, MD, Tommaso Caravita, MD, Antonietta Pia Falcone, MD, Francesca Patriarca, MD, Stefano Pulini, Paola Finsinger, MD, Giovannino Ciccone, Paolo Corradini, MD, Agostina Siniscalchi, MD, Francesca Donato, Dina Ben Yehuda, Massimo Offidani, MD, Jiri Minarik, MD PhD, Roberto Ria, MD, Federica Cavallo, MD, Lucio Catalano, MD, Maide Cavalli, MD, Ludek Pour, Doc, MD PhD, Maria Teresa Petrucci, MD, Izhar Hardan, MD, Mario Boccadoro, MD, Andrew Spencer, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 198.
https://doi.org/10.1182/blood.V124.21.198.198
Published: 2014
Journal Articles

A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma

Sara Bringhen, MD, Chiara Cerrato, MD, Maria Teresa Petrucci, MD, Mariella Genuardi, MD, Fabiana Gentilini, MD, Concetta Conticello, Stefania Oliva, Lucia Pantani, MD, Massimo Offidani, MD, Carmela Palladino, Giulia Benevolo, MD, Vittorio Montefusco, MD, Monica Astolfi, Oreste Villani, Agostina Siniscalchi, MD, Alberto Rocci, Lorenzo De Paoli, Mario Boccadoro, MD, Pieter Sonneveld, MD, PhD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 685.
https://doi.org/10.1182/blood.V122.21.685.685
Published: 2013
Journal Articles

Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) for Newly Diagnosed Multiple Myeloma (MM) Patients

Antonio Palumbo, MD, Sara Bringhen, Oreste Villani, Agostina Siniscalchi, MD, Eleonora Russo, MD, PhD, Giuseppina Uccello, MD, Chiara Cerrato, MD, Milena Gilestro, Davide Rossi, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 730.
https://doi.org/10.1182/blood.V120.21.730.730
Published: 2012